Research Article

Levels of Inflammatory Cytokines in Type 2 Diabetes Patients with Different Urinary Albumin Excretion Rates and Their Correlation with Clinical Variables

Table 1

Comparison of the general status and study data between diabetes groups and control group.

CD1D2D3

Number861129356
Age (years)55.2 ± 12.454.9 ± 13.153.7 ± 12.562.6 ± 11.4
BMI (Kg/m2)26.5 ± 3.126.3 ± 3.726.2 ± 2.926.8 ± 3.7
Course (year)8.9 ± 1.39.9 ± 1.711.8 ± 2.4
SBP (mmHg)111.3 ± 10.3124.0 ± 14.3b130.9 ± 16.9b135.5 ± 17.3b
DBP (mmHg)71.4 ± 8.377.8 ± 6.5b82.7 ± 7.8b86.1 ± 14.5b
SCr ( mol/L)63.62 ± 8.7964.96 ± 15.2769.02 ± 20.3278.49 ± 24.12
BUN (mmol/L)4.09 ± 1.016.12 ± 1.316.41 ± 1.376.76 ± 1.70
HbA1c (%)7.80 ± 3.288.89 ± 2.599.97 ± 2.91c
TG (mmol/L)1.69 ± 1.011.71 ± 0.97 1.99 ± 1.032.13 ± 1.16
TC (mmol/L)4.33 ± 0.775.07 ± 0.83b5.36 ± 1.35b6.40 ± 1.76b
LDL-C (mmol/L)1.92 ± 0.333.02 ± 0.67b2.80 ± 1.23a3.97 ± 1.31bcf
HDL-C (mmol/L)1.15 ± 0.121.17 ± 0.22 1.13 ± 0.311.17 ± 0.30
Hs-CRP (mmol/L)1.03 ± 0.942.41 ± 1.07a3.95 ± 1.18bd4.51 ± 1.89bdf
TNF-α (mg/mL)1.01 ± 0.451.99 ± 0.56a2.73 ± 0.72bd4.10 ± 0.95bdf
UMCP-1/Ucr (ng/mg)4.51 ± 2.29 24.70 ± 5.37a70.59 ± 18.93bd122.85 ± 63.76bdf
SAA (ug/L)163.90 ± 37.13318.31 ± 34.35a490.13 ± 37.24bd665.04 ± 64.13bdf
Ln (UAE/Ucr)*2.19 ± 0.602.37 ± 0.86a4.08 ± 0.58bd7.34 ± 0.90bdf

BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; BUN: blood urea nitrogen; SCr: serum creatinine; HbA1c: glycohemoglobin A1c; TG: triglyceride; LDL-C: low density lipoprotein cholesterol; HDL-C: high density lipoprotein cholesterol; hs-CRP: high sensitivity C-reactive protein; TNF-α: tumor necrosis factor alpha; uMCP-1: urinary monocyte chemoattractant protein-1; SAA: serum amyloid-A; UAE/Ucr: urine albumin excretion/urinary creatinine.
, diabetic patients versus control; , D2 and D3 versus D1; , D3 versus D2.
*Since the figures of UAE/Ucr were not normally distributed, they were transitioned with ln here (similarly hereinafter).